Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
MATRIX-001 will examine the safety, PK, modeled PD, and acceptability of inserts containing the combination of TAF and EVG applied vaginally, daily for 3 days, then every other day for 14 days. The inserts are ultimately intended to be the basis of an event-driven, on-demand method for prevention of HIV and HSV sexual infection.
Epistemonikos ID: 2f492d3ba250949696dcb24e4ca88f8163e2de7d
First added on: May 15, 2024